187 related articles for article (PubMed ID: 31931103)
1. Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (-) and the eIF4A-inhibitor Silvestrol.
Müller C; Obermann W; Schulte FW; Lange-Grünweller K; Oestereich L; Elgner F; Glitscher M; Hildt E; Singh K; Wendel HG; Hartmann RK; Ziebuhr J; Grünweller A
Antiviral Res; 2020 Mar; 175():104706. PubMed ID: 31931103
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Hepatitis E Virus Spread by the Natural Compound Silvestrol.
Glitscher M; Himmelsbach K; Woytinek K; Johne R; Reuter A; Spiric J; Schwaben L; Grünweller A; Hildt E
Viruses; 2018 Jun; 10(6):. PubMed ID: 29865243
[TBL] [Abstract][Full Text] [Related]
3. The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo.
Müller C; Obermann W; Karl N; Wendel HG; Taroncher-Oldenburg G; Pleschka S; Hartmann RK; Grünweller A; Ziebuhr J
Antiviral Res; 2021 Feb; 186():105012. PubMed ID: 33422611
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Zika Virus Replication by Silvestrol.
Elgner F; Sabino C; Basic M; Ploen D; Grünweller A; Hildt E
Viruses; 2018 Mar; 10(4):. PubMed ID: 29584632
[TBL] [Abstract][Full Text] [Related]
5. Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity.
Obermann W; Friedrich A; Madhugiri R; Klemm P; Mengel JP; Hain T; Pleschka S; Wendel HG; Hartmann RK; Schiffmann S; Ziebuhr J; Müller C; Grünweller A
Viruses; 2022 Mar; 14(3):. PubMed ID: 35336926
[TBL] [Abstract][Full Text] [Related]
6. The natural compound silvestrol is a potent inhibitor of Ebola virus replication.
Biedenkopf N; Lange-Grünweller K; Schulte FW; Weißer A; Müller C; Becker D; Becker S; Hartmann RK; Grünweller A
Antiviral Res; 2017 Jan; 137():76-81. PubMed ID: 27864075
[TBL] [Abstract][Full Text] [Related]
7. The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
Todt D; Moeller N; Praditya D; Kinast V; Friesland M; Engelmann M; Verhoye L; Sayed IM; Behrendt P; Dao Thi VL; Meuleman P; Steinmann E
Antiviral Res; 2018 Sep; 157():151-158. PubMed ID: 30036559
[TBL] [Abstract][Full Text] [Related]
8. Stress Granule-Inducing Eukaryotic Translation Initiation Factor 4A Inhibitors Block Influenza A Virus Replication.
Slaine PD; Kleer M; Smith NK; Khaperskyy DA; McCormick C
Viruses; 2017 Dec; 9(12):. PubMed ID: 29258238
[TBL] [Abstract][Full Text] [Related]
9. Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses.
Müller C; Schulte FW; Lange-Grünweller K; Obermann W; Madhugiri R; Pleschka S; Ziebuhr J; Hartmann RK; Grünweller A
Antiviral Res; 2018 Feb; 150():123-129. PubMed ID: 29258862
[TBL] [Abstract][Full Text] [Related]
10. Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates-A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus Pandemics.
Taroncher-Oldenburg G; Müller C; Obermann W; Ziebuhr J; Hartmann RK; Grünweller A
Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33807988
[TBL] [Abstract][Full Text] [Related]
11. Silvestrol Inhibits Chikungunya Virus Replication.
Henss L; Scholz T; Grünweller A; Schnierle BS
Viruses; 2018 Oct; 10(11):. PubMed ID: 30380742
[TBL] [Abstract][Full Text] [Related]
12. Natural antiviral compound silvestrol modulates human monocyte-derived macrophages and dendritic cells.
Blum L; Geisslinger G; Parnham MJ; Grünweller A; Schiffmann S
J Cell Mol Med; 2020 Jun; 24(12):6988-6999. PubMed ID: 32374474
[TBL] [Abstract][Full Text] [Related]
13. Total synthesis of a biotinylated rocaglate: Selective targeting of the translation factors eIF4AI/II.
Chambers JM; Lindqvist LM; Savage GP; Rizzacasa MA
Bioorg Med Chem Lett; 2016 Jan; 26(2):262-264. PubMed ID: 26718843
[TBL] [Abstract][Full Text] [Related]
14. A forward genetic screen identifies modifiers of rocaglate responsiveness.
Shen L; Pugsley L; Cencic R; Wang H; Robert F; Naineni SK; Sahni A; Morin G; Zhang W; Nijnik A; Porco JA; Langlais D; Huang S; Pelletier J
Sci Rep; 2021 Sep; 11(1):18516. PubMed ID: 34531456
[TBL] [Abstract][Full Text] [Related]
15. Identification of structurally re-engineered rocaglates as inhibitors against hepatitis E virus replication.
Praditya DF; Klöhn M; Brüggemann Y; Brown LE; Porco JA; Zhang W; Kinast V; Kirschning A; Vondran FWR; Todt D; Steinmann E
Antiviral Res; 2022 Aug; 204():105359. PubMed ID: 35728703
[TBL] [Abstract][Full Text] [Related]
16. Amidino-Rocaglates: A Potent Class of eIF4A Inhibitors.
Chu J; Zhang W; Cencic R; Devine WG; Beglov D; Henkel T; Brown LE; Vajda S; Porco JA; Pelletier J
Cell Chem Biol; 2019 Nov; 26(11):1586-1593.e3. PubMed ID: 31519508
[TBL] [Abstract][Full Text] [Related]
17. Comparing the Effects of Rocaglates on Energy Metabolism and Immune Modulation on Cells of the Human Immune System.
Schiffmann S; Henke M; Seifert M; Ulshöfer T; Roser LA; Magari F; Wendel HG; Grünweller A; Parnham MJ
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982945
[TBL] [Abstract][Full Text] [Related]
18. Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor.
Iwasaki S; Floor SN; Ingolia NT
Nature; 2016 Jun; 534(7608):558-61. PubMed ID: 27309803
[TBL] [Abstract][Full Text] [Related]
19. 1-Aminomethyl SAR in a novel series of flavagline-inspired eIF4A inhibitors: Effects of amine substitution on cell potency and in vitro PK properties.
Nilewski C; Michels TD; Packard GK; Xiang AX; Sprengeler PA; Eam B; Fish S; Thompson PA; Wegerski CJ; Nevarez A; Clarine J; Sperry S; Ernst JT; Reich SH
Bioorg Med Chem Lett; 2021 Sep; 47():128111. PubMed ID: 34353608
[TBL] [Abstract][Full Text] [Related]
20. Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatome.
Ho JJD; Cunningham TA; Manara P; Coughlin CA; Arumov A; Roberts ER; Osteen A; Kumar P; Bilbao D; Krieger JR; Lee S; Schatz JH
Cell Rep; 2021 Oct; 37(2):109806. PubMed ID: 34644561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
